Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The macrophage receptor with collagenous structure (MARCO) is a trimeric glycoprotein on the surface of macrophages and belongs to the Scavenger receptor (SR). MARCO has a conserved 110 amino acid fragment in the C-terminal specific domain, which is rich in cysteine and is therefore referred to as a cysteine-rich receptor domain and is directly or indirectly related to the defense function of the body. MARCO is mainly distributed on various macrophage membranes and participates in the body's immune response to inhaled particulate matter and pathogens. Its expression is often affected by bacteria, exogenous toxins and particles.
MARCO Mediates the Identification and Phagocytosis of Dust Particles
MARCO is the most important receptor for binding to non-opsonin-dependent particles (such as SiO2). It also interacts with a variety of receptors, including Toll-like receptors, to regulate the body's immune response. The exact function of SR is currently uncertain, but is considered to be an important part of the innate immune response, and its expression is generally up-regulated in the presence of infection. Due to the complex nature of SR, the researchers suggest that it may have multiple functions, including endocytosis, cell adhesion, cell transport, and intracellular signal transduction, and participate in the binding and uptake of polyanionic particles.
By immunoprecipitation, MARCO monoclonal antibody PAL-1 antibody binds to a protein of about 70 kD on the surface of macrophages, and its mRNA has high homology with the mRNA corresponding to human MARCO. At the same time, studies have shown that the use of cell transfection and co-immunoprecipitation to detect the interaction between human MARCO and dust particles also demonstrates that MARCO plays a crucial role in the body's defense against inhaled particles.

Figure 1. Role of Macrophages in Autoimmunity. (Gordon, et al. 2014)
The Role of MARCO in Silicosis
Silicosis is a systemic disease characterized by fibrosis of lung tissue caused by long-term inhalation of dust with a high level of silicon dioxide (SiO2). After entering the body, SiO2 dust first interacts with Alveolar macrophage (AM), including the recognition of particles by MARCO and the encapsulation and phagocytosis of macrophages. If SiO2 is not successfully removed from the lungs, it can cause a persistent inflammatory response that can eventually lead to pulmonary interstitial fibrosis.
Studies have shown that the use of C57BL /6 wild-type mice and MARCO - / - mice to determine the role of MARCO in the pathological changes of SiO2 induced lung, the results showed that the AM expression of mice treated with SiO2 increased MARCO, while phosphate buffer and TiO2 The treatment group MARCO did not increase; compared with wild mice, MARCO - / - mice exposed to SiO2 showed stronger inflammatory response and lung injury, but the degree of fibrosis was not significantly increased. Studies have shown that experiments using SR knockout mice did not reveal the formation of pulmonary fibrosis.
The study found that there was a positive correlation between the expression of macrophage SR1, MARCO and the apoptotic protein Caspase-3 on the AM surface of silicosis patients, indicating that SR-A is associated with AM death in silicosis patients. After the polymorphic guanine nucleotides of SD rats blocked the binding of MARCO to SiO2, the level of AM oxidative stress was significantly reduced, and the degree of pulmonary fibrosis was weakened, but inflammatory lesions still existed. Further studies have found that the reduction in fibrosis may be related to the inhibition of EMT by poly-guanine nucleotides. In addition, MARCO is also associated with susceptibility to chronic obstructive pulmonary disease, tuberculosis, and lung infections.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.